[Occurrence of bleeding in women using combined hormonal contraceptives (ethinylestradiol 35 micrograms/norgestimate 250 micrograms in relation to regularity of administration and cycle start day].

To assess the frequency of irregular intermenstrual bleeding in combined oral contraceptive (ethinylestradiol 35 micrograms/norgestimate 250 micrograms, COC) users and the influence of regularity of pill use on this frequency; to assess the occurrence of withdrawal bleeding during weekends in women using the COC from the first Sunday in the cycle (Sunday start method).
Prospective, open, non-comparative, multicenter study in 27 centers.
The first day of the pill use, occurrence of intermenstrual and withdrawal bleeding and regularity of use were assessed by means of patient's bleeding diary. Body weight, blood pressure and side effects were monitored before the oral contraceptive use and after the third cycle.
358 (94%) of 382 women completed the study. Frequency of intermenstrual bleeding was generally low (6.7%, 5.0% and 5.0% in the first, second and third cycle) and highly influenced by regularity of pill use (2.6%, 0% a 1% in regular users versus 30.2%, 32.1% a 24.2% in irregular users). 28%, 40% and 47% of Sunday start users achieved bleeding-free weekends after the first, second and third cycle. Body weight and blood pressure did not change during the study.
Frequency of intermenstrual (breakthrough) bleeding during the first three months of COC use is highly influenced by regularity of use. In regular users of monophasic COC containing ethinylestradiol 35 micrograms/norgestimate 250 micrograms the frequency of intermenstrual bleeding is bellow 2.6%. In Sunday start users the proportion of women with bleeding-free weekends (i.e. weekends without the occurrence of withdrawal bleeding) increases to 47% after the third cycle.
AuthorsV Paseková, K Chroust
JournalCeská gynekologie / Ceská lékarská spolecnost J. Ev. Purkyne (Ceska Gynekol) Vol. 68 Issue 2 Pg. 84-8 (Mar 2003) ISSN: 1210-7832 [Print] Czech Republic
Vernacular TitleVýskyt krvácení u uzivatelek kombinované hormonální antikoncepce (etinylestradiol 35 micrograms/norgestimát 250 micrograms) v závislosti na pravidelnosti a způsobu zahájení uzívání.
PMID12749175 (Publication Type: English Abstract, Journal Article, Multicenter Study)
Chemical References
  • Contraceptives, Oral, Hormonal
  • norgestimate, ethinyl estradiol drug combination
  • Norgestrel
  • Ethinyl Estradiol
  • Ethinyl Estradiol-Norgestrel Combination
  • Adolescent
  • Adult
  • Contraceptives, Oral, Hormonal (administration & dosage, adverse effects)
  • Ethinyl Estradiol
  • Ethinyl Estradiol-Norgestrel Combination (administration & dosage, adverse effects, analogs & derivatives)
  • Female
  • Humans
  • Middle Aged
  • Norgestrel (analogs & derivatives)
  • Patient Compliance
  • Prospective Studies
  • Uterine Hemorrhage (chemically induced)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: